Symptoms of severe gastroparesis may include: Persistent nausea Severe vomiting Stomach pains Bloating Feeling full after eating small amounts Food staying in the stomach too long Loss of appetite Unintended weight loss Dehydration Malnutrition Blood sugar instability Repeated emergency room visits Severe gastroparesis may lead to major medical costs when patients need diagnostic testing, IV fluids, hospitalization, prescription medication, feeding support, or long-term gastrointestinal care
Mazdutide is a synthetic peptide that acts as a GCGR+GLP-1R dual agonist, currently being developed in China in collaboration with Sinopharm for the treatment of type 2 diabetes and obesity.
Not absent, which would be concerning, but manageable
Other GLP-1 drugs have been approved as diabetes medication and prescribed off-label for weight management
The following types of evidence may be pertinent in a potential Ozempic Lawsuit claim: Your legal representative will assist you in collecting the necessary evidence, however, you can initiate this process independently to ensure you are adequately prepared for any legal proceedings
We need more data on the long-term effects and other outcomes related to cardiovascular health, particularly in lower-risk individuals